<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35312860</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1432-5233</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>59</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Acta diabetologica</Title>
          <ISOAbbreviation>Acta Diabetol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Significant and persistent improvements in time in range and positive emotions in children and adolescents with type 1 diabetes using a closed-loop control system after attending a virtual educational camp.</ArticleTitle>
        <Pagination>
          <StartPage>837</StartPage>
          <EndPage>842</EndPage>
          <MedlinePgn>837-842</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00592-022-01878-z</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the six-month impact of the advanced automated functions of a closed-loop control (CLC) system (Control-IQ) and a virtual educational camp (vEC) on emotions and time in range (TIR) of children and adolescents with type 1 diabetes.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Children and their parents participated in a three-day vEC. Clinical, glucose, and emotion data were evaluated before, just after, and six months after the vEC. Emotions were evaluated using adapted Plutchik's and Geneva Emotion Wheels.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Forty-three children and adolescents (7-16 years) showed significant improvements in positive emotions immediately and six months after the vEC (67% and 65% vs 38%, p &lt; 0.05, respectively), while mixed emotions were reduced (32% and 15% vs 61%, p &lt; 0.05 and p &lt; 0.001, respectively). The median percentage TIR increased from 64% (IQR 54-72) to 75% (IQR 70-82) with Control-IQ (p &lt; 0.001) six months after the vEC.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Positive emotions (joy, serenity, and satisfaction) significantly improved while mixed emotions were significantly worse six months after the initiation of a CLC system (Control-IQ) and a vEC.</AbstractText>
          <CopyrightInformation>© 2022. Springer-Verlag Italia S.r.l., part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Rabbone</LastName>
            <ForeName>Ivana</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health and Science, University of Piemonte Orientale, Novara, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Savastio</LastName>
            <ForeName>Silvia</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health and Science, University of Piemonte Orientale, Novara, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pigniatiello</LastName>
            <ForeName>Ciro</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health and Science, University of Piemonte Orientale, Novara, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carducci</LastName>
            <ForeName>Chiara</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Diabetes Unit, Pediatric Hospital Bambino Gesù, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Berioli</LastName>
            <ForeName>Maria Giulia</ForeName>
            <Initials>MG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, University of Perugia, Perugia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cherubini</LastName>
            <ForeName>Valentino</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Women's and Children's Health, G. Salesi Hospital, Ancona, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lo Presti</LastName>
            <ForeName>Donatella</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, University of Catania, Catania, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maltoni</LastName>
            <ForeName>Giulio</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Unit, IRCCS, Azienda Ospedaliero-Universitaria, Bologna, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mameli</LastName>
            <ForeName>Chiara</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Buzzi Children's Hospital, Università Di Milano, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marigliano</LastName>
            <ForeName>Marco</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Diabetes and Metabolic Disorders Unit, University of Verona, Verona, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Minuto</LastName>
            <ForeName>Nicola</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Clinic, IRCCS G. Gaslini, Genova, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mozzillo</LastName>
            <ForeName>Enza</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Translational Medical Science, Section of Pediatrics, Regional Center of Pediatric Diabetes, University of Naples Federico II, Napoli, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Piccinno</LastName>
            <ForeName>Elvira</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Metabolic Diseases and Diabetology, Children's Hospital Giovanni XXIII, Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Predieri</LastName>
            <ForeName>Barbara</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical and Surgical Sciences of the Mother, Children and Adults, University of Mdena and Reggio Emilia, Modena, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rigamonti</LastName>
            <ForeName>Andrea</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Diabetes Research Institute, San Raffaele Institute, Milano, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ripoli</LastName>
            <ForeName>Carlo</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics and Microcythemia, ARNAS G. Brotzu, Cagliari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schiaffini</LastName>
            <ForeName>Riccardo</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Diabetes Unit, Pediatric Hospital Bambino Gesù, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lombardo</LastName>
            <ForeName>Fortunato</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Human Pathology in adult and developmental age, University of Messina, Messina, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tinti</LastName>
            <ForeName>Davide</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, University of Torino, Torino, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Toni</LastName>
            <ForeName>Sonia</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Diabetology and Endocrinology Unit, Meyer Children's Hospital, Firenze, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zanfardino</LastName>
            <ForeName>Angela</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Regional Center of Pediatric Diabetology, University of Campania "L. Vanvitelli", Napoli, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scaramuzza</LastName>
            <ForeName>Andrea Enzo</ForeName>
            <Initials>AE</Initials>
            <Identifier Source="ORCID">0000-0002-1518-8515</Identifier>
            <AffiliationInfo>
              <Affiliation>Pediatric Diabetes, Endocrinology and Nutrition, Division of Pediatrics, ASST Cremona, Cremona, Italy. a.scaramuzza@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>vEC Study Group</CollectiveName>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Acta Diabetol</MedlineTA>
        <NlmUniqueID>9200299</NlmUniqueID>
        <ISSNLinking>0940-5429</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004644" MajorTopicYN="N">Emotions</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007332" MajorTopicYN="N">Insulin Infusion Systems</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Adolescents</Keyword>
        <Keyword MajorTopicYN="N">Advanced hybrid closed loop</Keyword>
        <Keyword MajorTopicYN="N">Children</Keyword>
        <Keyword MajorTopicYN="N">Closed-loop control</Keyword>
        <Keyword MajorTopicYN="N">Emotions</Keyword>
        <Keyword MajorTopicYN="N">Type 1 diabetes</Keyword>
        <Keyword MajorTopicYN="N">Virtual educational camp</Keyword>
      </KeywordList>
      <CoiStatement>IR serves on the advisory board for Sanofi Aventis and Movi and has spoken for Aboca, Abbott, Sanofi Aventis and Eli Lilly. VC serves on the advisory board for Insulet and Eli Lilly, and his institution has received research support from AstraZeneca, Eli Lilly, and Dompè. DL has spoken for Abbott and has received support for attending meeting from Eli Lilly. AR has spoken for Menarini and Eli Lilly and has received support for attending meeting from Abbott. MM serves on the advisory board for Medtronic and Movi, has received support for attending meeting from Movi and has spoken for Abbott and Roche. EP serves on the advisory board for Medtronic and has received support for attending meeting from Movi. BP serves on the advisory board for Eli Lilly, has received support for attending meeting from Movi, Eli Lilly, Roche, and Ferring and has spoken for Sandoz. CR serves on the advisory board for Eli Lilly and has received support for attending meeting from Novo Nordisk. RS has spoken for Abbott and Lilly, has received support for attending meeting from Medtronic and Movi, and has served on advisory boards for Abbott and Sanofi. ST has spoken for Eli Lilly, Abbott, and Sanofi Aventis and serves on the advisory board for Movi. AES has spoken for Sanofi and Abbott, has received support for attending meeting from Movi and has served on the advisory board for Medtronic and Movi. CM has served on the advisory board for Novo Nordisk, Sanofi Aventis, and Abbott and has spoken for Aboca, Eli Lilly, Theras, Novo Nordisk, Sanofi Aventis, and AMryt. RB has served on the advisory board for NovoNordisk, Eli Lilly, Sanofi Aventis, Abbott, Medtronic, Movi, Roche, and Ypsomed and has received support for attending a meeting from Movi and has spoken for Eli Lilly, Abbott, and Sanofi Aventis. The other authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>21</Day>
          <Hour>17</Hour>
          <Minute>18</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35312860</ArticleId>
        <ArticleId IdType="pmc">PMC8935105</ArticleId>
        <ArticleId IdType="doi">10.1007/s00592-022-01878-z</ArticleId>
        <ArticleId IdType="pii">10.1007/s00592-022-01878-z</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Cherubini V, Rabbone I, Berioli MG, et al.  Effectiveness of a closed-loop control system and a virtual educational camp for children and adolescents with type 1 diabetes: a prospective, multicentre, real-life study. Diabetes Obes Metab. 2021 doi: 10.1111/dom.14491.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/dom.14491</ArticleId>
            <ArticleId IdType="pubmed">34227214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinberg DM, Anderson BJ, de Wit M, Hilliard ME. Positive well-being in youth with type 1 diabetes during early adolescence. J Early Adolesc. 2018;38:1215–1235. doi: 10.1177/0272431617692444.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0272431617692444</ArticleId>
            <ArticleId IdType="pmc">PMC6177217</ArticleId>
            <ArticleId IdType="pubmed">30319165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iturralde E, Rausch JR, Weissberg-Benchell J, Hood KK. Diabetes-related emotional distress over time. Pediatrics. 2019;143:e20183011. doi: 10.1542/peds.2018-3011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.2018-3011</ArticleId>
            <ArticleId IdType="pmc">PMC6564058</ArticleId>
            <ArticleId IdType="pubmed">31043453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richmond D, Sibthorp J, Wilson C. Understanding the role of summer camps in the learning landscape: an exploratory sequential study. J Youth Develop. 2021;14:9–30. doi: 10.5195/jyd.2019.780.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5195/jyd.2019.780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franceschi R, Micheli F, Mozzillo E, et al.  Intermittently scanned and continuous glucose monitor systems: a systematic review on psychological outcomes in pediatric patients. Front Pediatr. 2021;9:660173. doi: 10.3389/fped.2021.660173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fped.2021.660173</ArticleId>
            <ArticleId IdType="pmc">PMC8131655</ArticleId>
            <ArticleId IdType="pubmed">34026692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knox ECL, Quirk H, Glazebrook C, Randell T, Blake H. Impact of technology-based interventions for children and young people with type 1 diabetes on key diabetes self-management behaviours and prerequisites: a systematic review. BMC Endocr Disord. 2019;19:7. doi: 10.1186/s12902-018-0331-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12902-018-0331-6</ArticleId>
            <ArticleId IdType="pmc">PMC6329145</ArticleId>
            <ArticleId IdType="pubmed">30630442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forlenza GP, Messer LH, Berget C, Wadwa RP, Driscoll KA. Biopsychosocial factors associated with satisfaction and sustained use of artificial pancreas technology and its components: a call to the technology field. Curr Diab Rep. 2018;18:114. doi: 10.1007/s11892-018-1078-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11892-018-1078-1</ArticleId>
            <ArticleId IdType="pmc">PMC6535227</ArticleId>
            <ArticleId IdType="pubmed">30259309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adams RN, Tanenbaum ML, Hanes SJ, et al.  Psychosocial and human factors during a trial of a hybrid closed loop system for type 1 diabetes management. Diabetes Technol Ther. 2018;20:648–653. doi: 10.1089/dia.2018.0174.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/dia.2018.0174</ArticleId>
            <ArticleId IdType="pubmed">30239219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vesco AT, Jedraszko AM, Garza KP, Weissberg-Benchell J. Continuous glucose monitoring associated with less diabetes-specific emotional distress and lower A1c among adolescents with type 1 diabetes. J Diabetes Sci Technol. 2018;12:792–799. doi: 10.1177/1932296818766381.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1932296818766381</ArticleId>
            <ArticleId IdType="pmc">PMC6134305</ArticleId>
            <ArticleId IdType="pubmed">29595061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oldham V, Mumford B, Lee D, Jones J, Das G. Impact of insulin pump therapy on key parameters of diabetes management and diabetes related emotional distress in the first 12 months. Diabetes Res Clin Pract. 2020;166:108281. doi: 10.1016/j.diabres.2020.108281.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.diabres.2020.108281</ArticleId>
            <ArticleId IdType="pubmed">32628980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jonauskaite D, Abu-Akel A, Dael N, et al.  Universal patterns in color-emotion associations are further shaped by linguistic and geographic proximity. Psychol Sci. 2020;31:1245–1260. doi: 10.1177/0956797620948810.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0956797620948810</ArticleId>
            <ArticleId IdType="pubmed">32900287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Plutchik R. The nature of emotions: human emotions have deep evolutionary roots, a fact that may explain their complexity and provide tools for clinical practice. Am Sci. 2001;89(4):344–350. doi: 10.1511/2001.4.344.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1511/2001.4.344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scherer KR. What are emotions? And how can they be measured? Soc Sci Inf. 2005;44:695–729. doi: 10.1177/0539018405058216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0539018405058216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jonauskaite D, Parraga CA, Quiblier M, Mohr C. Feeling blue or seeing red? Similar patterns of emotion associations with colour patches and colour terms. Iperception. 2020;11(1):2041669520902484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7027086</ArticleId>
            <ArticleId IdType="pubmed">32117561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fegan-Bohm K, Weissberg-Benchell J, DeSalvo D, Gunn S, Hilliard M. Camp for youth with type 1 diabetes. Curr Diab Rep. 2016;16:68. doi: 10.1007/s11892-016-0759-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11892-016-0759-x</ArticleId>
            <ArticleId IdType="pmc">PMC4931894</ArticleId>
            <ArticleId IdType="pubmed">27292106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinsker JE, Müller L, Constantin A, et al.  Real-world patient-reported outcomes and glycemic results with initiation of Control-IQ technology. Diabetes Technol Ther. 2021;23:120–127. doi: 10.1089/dia.2020.0388.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/dia.2020.0388</ArticleId>
            <ArticleId IdType="pmc">PMC7868573</ArticleId>
            <ArticleId IdType="pubmed">32846114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Duinkerken E, Snoek FJ, de Wit M. The cognitive and psychological effects of living with type 1 diabetes: a narrative review. Diabetic Med. 2020;37:555–563. doi: 10.1111/dme.14216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/dme.14216</ArticleId>
            <ArticleId IdType="pmc">PMC7154747</ArticleId>
            <ArticleId IdType="pubmed">31850538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pals RAS, Hviid P, Cleal B, Grabowski D. Demanding devices—Living with diabetes devices as a pre-teen. Soc Sci Med. 2021;286:114279. doi: 10.1016/j.socscimed.2021.114279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.socscimed.2021.114279</ArticleId>
            <ArticleId IdType="pubmed">34428602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Commissariat PV, Roethke LC, Finnegan JL, et al.  Youth and parent preferences for an ideal AP system: It is all about reducing burden. Pediatr Diabetes. 2021;22(7):1063–1070. doi: 10.1111/pedi.13252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/pedi.13252</ArticleId>
            <ArticleId IdType="pmc">PMC8530854</ArticleId>
            <ArticleId IdType="pubmed">34324772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hood K, Laffel LM, Danne T, et al.  Lived experience of advanced hybrid closed-loop versus hybrid closed loop: patient-reported outcomes and perspectives. Diabetes Technol Ther. 2021;12:857–861. doi: 10.1089/dia.2021.0153.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/dia.2021.0153</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
